Free Access
Med Sci (Paris)
Volume 19, Number 8-9, Août-Septembre 2003
Page(s) 827 - 833
Section M/S Revues
Published online 15 August 2003
  1. Owen OE, Reichard GA, Patel MS, Boden G. Energy metabolism in feasting and fasting. In: Klachko DM, Anderson RR, Heimberg M, eds. Hormone and energy metabolism. New York: Plenum Press, 1979: 169–88. [Google Scholar]
  2. Reaven GM, Hollenbeck CB, Jen CY, Wu MS, Chen YDI. Measurement of plasma glucose, free fatty acid, lactate and insulin for 24 h in patients with NIDDM. Diabetes 1988; 37: 1020–4. [Google Scholar]
  3. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; I: 785–9. [Google Scholar]
  4. Randle PJ, Kerbey AL, Espinal J. Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones. Diabetes Metab Rev 1988; 4: 623–8. [Google Scholar]
  5. Zierler KL. Fatty acids as substrates for heart and skeletal muscle. Circ Res 1976; 39: 459–63. [Google Scholar]
  6. Girard J. Rôle des acides gras libres dans l’insulinorésistance au cours du diabète non-insulinodépendant. Diabete Metab 1995; 21: 79–88. [Google Scholar]
  7. Boden G. Effects of free fatty acids on gluconeogenesis and glycogenolysis. Life Sci 2003; 72: 977–88. [Google Scholar]
  8. Girard J. Acides gras, insulinosécrétion et lipotoxicité. Med Ther Endocrinol 2000; 2 (suppl2): 29–36. [Google Scholar]
  9. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 1995; 44: 863–70. [Google Scholar]
  10. Unger RH, The physiology of cellular liporegulation. Annu Rev Physiol 2003; 65: 333–47. [Google Scholar]
  11. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106: 171–6. [Google Scholar]
  12. Griffin ME, Marcucci MJ, Cline GW, et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999; 48: 1270–4. [Google Scholar]
  13. Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996; 97: 2859–2865. [Google Scholar]
  14. Dresner A, Laurent D, Marcucci M, et al. Effects of free fatty acids on glucose transport and IRS- 1-associated phosphatidylinositol 3- kinase activity. J Clin Invest 1999; 103: 253–9. [Google Scholar]
  15. Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 2000; 275: 8456–60. [Google Scholar]
  16. Gavrilova O, Marcus- Samuels B, Graham D, et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000; 105: 271–8. [Google Scholar]
  17. Berne C. The metabolism of lipids in mouse pancreatic islets: the oxidation of fatty acids and ketone bodies. Biochem J 1975; 152: 661–6. [Google Scholar]
  18. Malaisse WJ, Malaisse- Lagae F, Sener A, Hellerström C. Participation of endogenous fatty acids in the secretory activity of the pancreatic β-cell. Biochem J 1985; 227: 995–1002. [Google Scholar]
  19. Grupping AY, Cnop M, Van Schravendijk C, Hannaert J, Van Berkel T, Pipeleers D. Low density lipoprotein binding and uptake by human and rat islet β-cells. Endocrinology 1997; 138: 4064–8. [Google Scholar]
  20. Stein DT, Esser V, Stevenson BE, et al. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 1996; 97: 2728–35. [Google Scholar]
  21. Mason TM, Goh T, Tchipashvili V, et al. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 1999; 48: 524–30. [Google Scholar]
  22. Paolisso G, Gambardella A, Amato L, et al. Opposite effects of short- and longterm fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 1995; 38: 1295–9. [Google Scholar]
  23. Prentki M, Joly E, El-Assaad W, Roduit R. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in β-cell adaptation and failure in the etiology of diabetes. Diabetes 2002; 51 (suppl3): S405–13. [Google Scholar]
  24. McGarry JD. What if Minkowski had been ageusic ? An alternative angle on diabetes. Science 1992; 258: 766–70. [Google Scholar]
  25. McGarry JD. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51: 7–18. [Google Scholar]
  26. Unger RH. How obesity causes diabetes in Zucker diabetic fatty rats. Trends Endocrinol Metab 1997; 8: 276–82. [Google Scholar]
  27. McGarry JD, Dobbins RL. Fatty acids, lipotoxicity and insulin secretion. Diabetologia 1999; 42: 128–38. [Google Scholar]
  28. Pick A, Clark J, Kubstrup C, et al. Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat. Diabetes 1998; 47: 358–64. [Google Scholar]
  29. Man ZW, Zhu M, Noma Y, et al. Impaired β-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes 1997; 46: 1718–24. [Google Scholar]
  30. Unger RH. Lipotoxic diseases. Annu Rev Med 2002; 53: 319–36. [Google Scholar]
  31. Unger RH, Zhou YT, Orci L. Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc Natl Acad Sci USA 1999; 96: 2327–32. [Google Scholar]
  32. Shimabukuro M, Zhou YT, Lee Y, Unger RH. Troglitazone lowers islet fat and restores β-cell function of Zucker diabetic fatty rats. J Biol Chem 1998; 273: 3547–50. [Google Scholar]
  33. Higa M, Zhou YT, Ravazzola M, Baetens D, Orci L, Unger RH. Troglitazone prevents mitochondrial alterations, β-cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci USA 1999; 96: 11513–8. [Google Scholar]
  34. Marshak S, Leibowitz G, Bertuzzi F, et al. Impaired β-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 1999; 48: 1230–6. [Google Scholar]
  35. Poitout V, Robertson RP. Secondary β-cell failure in type 2 diabetes. A convergence of glucotoxicity and lipotoxicity. Endocrinology 2002; 143: 339–42. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.